Aehr Test Systems — Form 10-Q Summary
Business context and period. The filing covers the three months ended August 31, 2013, Aehr Test Systems’ first quarter of fiscal 2014. The company designs, manufactures and markets semiconductor test and burn-in equipment, including ABTS and FOX systems, wafer-level products and related accessories and services. Figures below are in U.S. dollars; financial-statement amounts are in millions unless noted.
Financial results and liquidity
| Metric | Q1 FY2014 | Q1 FY2013 |
|---|---|---|
| Net sales | $3.752 million | $4.832 million |
| Gross profit / margin | $1.944 million / 51.8% | $2.456 million / 50.8% |
| Operating expenses | $2.101 million | $2.719 million |
| Operating loss | $0.157 million | $0.263 million |
| Net loss | $0.166 million | $0.296 million |
| Basic and diluted loss per share | $0.02 | $0.03 |
| Operating cash flow | $0.172 million provided | $0.272 million used |
Cash and cash equivalents were $2.435 million at August 31, 2013, versus $2.324 million at May 31, 2013. Working capital was $4.9 million. The company had $0.947 million outstanding on its $2.5 million credit facility, with $1.486 million available to borrow; it reported compliance with all covenants. Total liabilities were $6.392 million, including the line of credit and customer deposits/deferred revenue. No separate long-term debt balance is reported.
Operating cash generation was driven mainly by a $0.409 million increase in customer deposits and deferred revenue, including additional customer down payments; accounts receivable increased $0.216 million. Investing cash use was $0.006 million, and financing cash use was $0.095 million, primarily reflecting net line-of-credit repayments. Cash increased by $0.111 million, including a $0.040 million positive foreign-exchange effect.
Changes versus the prior comparable period
- Sales fell 22.4%, primarily because Test During Burn-in sales declined about $0.9 million and wafer-level product sales declined about $0.2 million.
- Gross profit decreased by about $0.5 million, while gross margin improved by 1.0 percentage point to 51.8%.
- SG&A fell 20.6% to $1.420 million, and R&D fell 26.8% to $0.681 million, primarily due to lower employment-related costs. The operating loss and net loss narrowed.
- Operating cash flow improved from a $0.272 million use to $0.172 million provided, helped by customer deposits and deferred revenue.
Outlook, commentary and risks
- Management expected existing cash, operating cash flows and credit-facility availability to meet working-capital and capital-equipment needs through fiscal 2014. It cautioned that financing could be needed after fiscal 2014 depending on growth and profitability, and that future financing availability and terms are uncertain.
- The credit facility was extended to August 22, 2014. The amendment gives the lender a security interest in the company’s intellectual property, in addition to other collateral.
- Customer concentration is high: the five largest customers contributed approximately 95% of quarterly sales; two customers accounted for approximately 64% and 27%. Loss, delay or cancellation of major orders could materially affect results. The company also reported that sales are often high-value, low-volume transactions and orders may be rescheduled or canceled with limited penalties.
- Other key risks include semiconductor-industry cyclicality and customer capital-spending changes; product acceptance and development risks for FOX and ABTS; supplier concentration and delivery disruption; foreign-currency exposure, particularly the Japanese yen; and potential pressure on cash from continuing operating losses.
- No legal proceedings were reported. Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Whether sales stabilize or recover, particularly for TDBI and wafer-level products, and whether the improved gross margin is sustained.
- Customer concentration, order timing and cancellation/rescheduling exposure, including the quarter’s major customer contributions.
- Cash conversion: operating cash flow relied in part on customer deposits and deferred revenue; monitor receivables, deposits and inventory alongside reported cash.
- Credit-facility availability, covenant compliance, borrowing costs and the implications of the lender’s expanded collateral rights.
- Whether management’s expectation of adequate resources through fiscal 2014 remains supportable as operating results and cash needs evolve.